Lack Of Diversity In Embryonic Stem Cell Lines Revealed By U-M Study

The most widely used human embryonic stem cell lines lack genetic diversity, a finding that raises social justice questions that must be addressed to ensure that all sectors of society benefit from stem cell advances, according to a University of Michigan research team. In the first published study of its kind, the U-M team analyzed 47 embryonic stem cell lines, including most of the lines commonly used by stem cell researchers. The scientists determined the genetic ancestry of each line and found that most were derived from donors of northern and western European ancestry…

Go to Source

People who read this also read

• Oncogene’s Secret Growth Formula Revealed By Embryonic Stem Cells
  A comprehensive new gene expression study in embryonic stem cells has uncovered a transcription control mechanism that is not only more pervasive than once thought but is also heavily regulated by the cancer-causing gene c-Myc. In research published in the April 30th edition of Cell, a team of White...
• StemCells, Inc. Welcomes Approval Of First Embryonic Stem Cell Lines Under New NIH Guidelines
  StemCells, Inc. (NASDAQ: STEM) announced that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009. The guidelines...
• NIH Authorizes First Embryonic Stem Cell Lines Under Obama Administration Policy
  NIH on Wednesday authorized the first 13 lines of embryonic stem cells for research under the Obama administration policy that allows the use of such lines after they pass a federal approval process, the Washington Post reports. According to NIH officials, 20 more lines are expected to be approved o...
• NIH Approves Federal Funding For 13 More Stem Cell Lines
  The Washington Post: Thirteen more lines of human embryonic stem cells are officially eligible for federal funding, since being approved by the National Institutes of Health. The Obama administration announced shortly after the President took office that restrictions would be lifted on the us...
• NIH Director Collins Defends Obama Administration Policy On Embryonic Stem Cell Research
  In a letter to the editor of the Washington Post about a recent article on embryonic stem cell research, NIH Director Francis Collins writes that he is "concerned that readers might come away ... confused about what is happening" at the agency. He adds that "stem cell research is progressing rapidly...